APA (7th ed.) Citation

Zeng, M., Chen, K., Tian, X., Zou, R., Feng, X., Li, C., . . . He, X. (2023). Clinical characteristics and prognosis analysis of patients with de novo ASXL1‐mutated AML treated with the C‐HUNAN‐AML‐15 protocol: A multicenter study by the South China Pediatric AML Collaborative Group. Cancer medicine (Malden, MA), 12(12), 13182-13192. https://doi.org/10.1002/cam4.6005

Chicago Style (17th ed.) Citation

Zeng, Minhui, et al. "Clinical Characteristics and Prognosis Analysis of Patients with De Novo ASXL1‐mutated AML Treated with the C‐HUNAN‐AML‐15 Protocol: A Multicenter Study by the South China Pediatric AML Collaborative Group." Cancer Medicine (Malden, MA) 12, no. 12 (2023): 13182-13192. https://doi.org/10.1002/cam4.6005.

MLA (9th ed.) Citation

Zeng, Minhui, et al. "Clinical Characteristics and Prognosis Analysis of Patients with De Novo ASXL1‐mutated AML Treated with the C‐HUNAN‐AML‐15 Protocol: A Multicenter Study by the South China Pediatric AML Collaborative Group." Cancer Medicine (Malden, MA), vol. 12, no. 12, 2023, pp. 13182-13192, https://doi.org/10.1002/cam4.6005.